ARMISTICE CAPITAL, LLC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.

Quarter-by-quarter ownership
ARMISTICE CAPITAL, LLC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$140,386,440
-7.3%
5,092,000
+1.1%
2.15%
-1.8%
Q2 2023$151,382,160
-3.9%
5,036,000
+15.8%
2.19%
-3.5%
Q1 2023$157,600,500
+1.4%
4,350,000
-0.1%
2.27%
-16.3%
Q4 2022$155,378,520
-0.1%
4,356,000
-5.2%
2.71%
+0.5%
Q3 2022$155,473,000
+14.1%
4,593,004
-2.5%
2.70%
+13.5%
Q2 2022$136,271,000
+36.0%
4,712,000
+52.0%
2.38%
+22.7%
Q1 2022$100,192,000
-16.9%
3,100,000
-25.0%
1.94%
-1.9%
Q4 2021$120,606,000
+16.0%
4,136,000
+6.1%
1.97%
+12.0%
Q3 2021$104,013,000
+1.6%
3,900,000
+17.3%
1.76%
-3.8%
Q2 2021$102,346,000
+14.6%
3,324,000
-2.6%
1.83%
-10.7%
Q1 2021$89,326,000
+13.8%
3,412,000
+9.4%
2.05%
-23.2%
Q4 2020$78,499,000
+17.7%
3,120,000
-2.5%
2.67%
+10.4%
Q3 2020$66,688,000
+27.2%
3,200,000
+44.9%
2.42%
+5.2%
Q2 2020$52,440,000
-2.8%
2,208,000
-26.4%
2.30%
-31.1%
Q1 2020$53,970,000
+32.9%
3,000,000
+75.2%
3.34%
+42.4%
Q4 2019$40,609,0001,712,0002.34%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 426,500$11,754,3403.96%
ASHFORD CAPITAL MANAGEMENT INC 916,747$25,274,7153.72%
ARMISTICE CAPITAL, LLC 5,092,000$140,386,4402.15%
S&T BANK/PA 215,578$5,9431.15%
Aristotle Capital Boston, LLC 1,187,981$32,752,6341.06%
RICE HALL JAMES & ASSOCIATES, LLC 544,468$15,010,9830.95%
Tributary Capital Management, LLC 352,429$9,716,4680.92%
Bridge City Capital, LLC 65,297$1,800,2380.91%
Integral Health Asset Management, LLC 220,000$6,065,4000.84%
Retirement Planning Co of New England, Inc. 51,608$1,422,8330.79%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders